Australia’s Therapeutic Goods Administration has introduced a single platform for online complaints relating to medical device advertising.
As of July, the agency has taken over the advertising complaint handling system, revamping the previous system to improve compliance with both drug and device regulations. Under the new system, the complaint form will be consolidated to give the TGA sole responsibility for handling complaints about device and drug advertising directed at the public.
The agency will continue requiring pre-approvals for advertisements through July 1, 2020, with the date on a pre-approval determining the serial number used for the applications. The TGA will continue to issue recommendations to advertisers during the transition from the existing 2015 code to when the new code takes effect on Jan. 1, 2019.